Innovus Pharmaceuticals Inc. (fka INNV)

[TrueTrades]

Can't recall a stock that has thrown so much fluff at the wire, and it's predictably hit zero effect level. The extra cash is coming from sales though, and while the co is diluting, evidenced by the outside trades, this CEO has done this before and is following a proven business plan.

Bottom feeding can still pay off well here but the volatility is going to dry up. Longer term I think this is a good investment. A structure adjustment (R/S) and move to exchange listing and the BOD will sell at a handsome premium, IMO.

headsortails2066: Debt pay down news an obvious precursor to your well-presumed 75% increase in sales PR coming for next Q.
§